DK1423708T3 - Sammensætninger og fremgangsmåder til bestemmelser af AA4RP - Google Patents
Sammensætninger og fremgangsmåder til bestemmelser af AA4RPInfo
- Publication number
- DK1423708T3 DK1423708T3 DK02781373T DK02781373T DK1423708T3 DK 1423708 T3 DK1423708 T3 DK 1423708T3 DK 02781373 T DK02781373 T DK 02781373T DK 02781373 T DK02781373 T DK 02781373T DK 1423708 T3 DK1423708 T3 DK 1423708T3
- Authority
- DK
- Denmark
- Prior art keywords
- aa4rp
- compositions
- methods
- relates
- determination
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000923 atherogenic effect Effects 0.000 abstract 2
- 238000011002 quantification Methods 0.000 abstract 2
- 239000000523 sample Substances 0.000 abstract 2
- 108010073614 apolipoprotein A-IV Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0111598A FR2829581A1 (fr) | 2001-09-07 | 2001-09-07 | Methodes de criblage de molecules utiles pour la prevention ou le traitement du syndrome metabolique, des maladies cardiovasculaires et de l'atherosclerose |
| FR0210205A FR2843395A1 (fr) | 2002-08-12 | 2002-08-12 | Composition et methodes pour le dosage de l'aa4rp |
| PCT/FR2002/003041 WO2003023408A1 (fr) | 2001-09-07 | 2002-09-06 | Compositions et methodes pour le dosage de l'aa4rp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1423708T3 true DK1423708T3 (da) | 2007-04-02 |
Family
ID=26213176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02781373T DK1423708T3 (da) | 2001-09-07 | 2002-09-06 | Sammensætninger og fremgangsmåder til bestemmelser af AA4RP |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040197823A1 (de) |
| EP (1) | EP1423708B1 (de) |
| JP (1) | JP2005502711A (de) |
| AT (1) | ATE347108T1 (de) |
| CA (1) | CA2459947A1 (de) |
| DE (1) | DE60216482T2 (de) |
| DK (1) | DK1423708T3 (de) |
| ES (1) | ES2275924T3 (de) |
| IL (1) | IL160531A0 (de) |
| WO (1) | WO2003023408A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7972802B2 (en) * | 2005-10-31 | 2011-07-05 | University Of Washington | Lipoprotein-associated markers for cardiovascular disease |
| US8241861B1 (en) | 2008-07-08 | 2012-08-14 | Insilicos, Llc | Methods and compositions for diagnosis or prognosis of cardiovascular disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0976824A1 (de) * | 1998-07-10 | 2000-02-02 | Amsterdam Molecular Therapeutics | An der Leberregenration beteiligtes Gen und Protein |
| EP1144444A3 (de) * | 1998-12-22 | 2002-01-02 | Genset | Kodierende nuleinsäuren für proteine mit signalsequenzen |
| US6455280B1 (en) * | 1998-12-22 | 2002-09-24 | Genset S.A. | Methods and compositions for inhibiting neoplastic cell growth |
| ES2289630T3 (es) * | 1999-03-08 | 2008-02-01 | Genentech, Inc. | Composiciones y procedimientos para el diagnostico de tumores. |
| EP1200576A2 (de) * | 1999-06-25 | 2002-05-02 | Genset | Kodierende nuleinsäuren für proteine mit signalsequenzen |
| CA2311201A1 (en) * | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
| US20020142953A1 (en) * | 2000-04-14 | 2002-10-03 | Ballinger Dennis G. | Materials and methods relating to lipid metabolism |
-
2002
- 2002-09-06 ES ES02781373T patent/ES2275924T3/es not_active Expired - Lifetime
- 2002-09-06 US US10/487,096 patent/US20040197823A1/en not_active Abandoned
- 2002-09-06 DE DE60216482T patent/DE60216482T2/de not_active Expired - Fee Related
- 2002-09-06 AT AT02781373T patent/ATE347108T1/de not_active IP Right Cessation
- 2002-09-06 CA CA002459947A patent/CA2459947A1/fr not_active Abandoned
- 2002-09-06 IL IL16053102A patent/IL160531A0/xx unknown
- 2002-09-06 WO PCT/FR2002/003041 patent/WO2003023408A1/fr not_active Ceased
- 2002-09-06 JP JP2003527428A patent/JP2005502711A/ja active Pending
- 2002-09-06 DK DK02781373T patent/DK1423708T3/da active
- 2002-09-06 EP EP02781373A patent/EP1423708B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2275924T3 (es) | 2007-06-16 |
| JP2005502711A (ja) | 2005-01-27 |
| ATE347108T1 (de) | 2006-12-15 |
| US20040197823A1 (en) | 2004-10-07 |
| EP1423708B1 (de) | 2006-11-29 |
| DE60216482D1 (de) | 2007-01-11 |
| CA2459947A1 (fr) | 2003-03-20 |
| IL160531A0 (en) | 2004-07-25 |
| EP1423708A1 (de) | 2004-06-02 |
| WO2003023408A1 (fr) | 2003-03-20 |
| DE60216482T2 (de) | 2007-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1379693A4 (de) | Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes | |
| WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
| ATE431854T1 (de) | Auf bio-barcodes beruhender nachweis von zielanalyten | |
| DK0820522T3 (da) | Assays og indretninger til detektering af ekstrahepatisk galdeatresi | |
| DK1513878T3 (da) | Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 | |
| WO2003016527A3 (en) | Process for the detection of oxidative stress and kit for its implementation | |
| WO2003064993A3 (en) | Methods and materials for detecting genetic material | |
| DK1639130T3 (da) | Prober, biblioteker og kits til analyse af blandinger af nukleinsyrer og metoder til opbygning af disse | |
| DK1098658T3 (da) | Manipulerede proteiner til detektering af analytter | |
| EP1687283A4 (de) | Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung | |
| DE60228557D1 (de) | Candida-nachweis | |
| ATE541054T1 (de) | Bio-barcode erkennung für zielmoleküle | |
| ATE408829T1 (de) | Verfahren und assaykits zum nachweis mononuklearer zellphänotypen | |
| CY1107621T1 (el) | Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα | |
| AU2003260457A1 (en) | A method and kit for the quantitative and/or qualitative detection of components in a sample | |
| DE60228952D1 (de) | Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren | |
| FI973561A7 (fi) | Menetelmä ja yhdisteitä analysoitavien aineiden määrittämiseksi remane nssimittausten avulla ja mainittujen yhdisteiden käyttö | |
| DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
| ATE383418T1 (de) | Verfahren und zusammensetzungen zur bestimmung glycierter proteine | |
| CA2434694A1 (en) | Detection and quantification of cripto-1 | |
| WO2006004958A3 (en) | Detection or measurement of antibodies to antigenic proteins in biological tissues or samples | |
| DK1173748T3 (da) | Fremgangsmåde og indretning til detektering af variationer af optiske egenskaber af en prøve i en analyseproces | |
| DE60216482D1 (de) | Zusammensetzungen und verfahren zum bestimmen von aa4rp | |
| DK1057021T3 (da) | Fremgangsmåde til måling af totalanalyt | |
| DE602004031571D1 (de) | Enzymhemmungsimmunverfahren |